198 related articles for article (PubMed ID: 25360300)
1. Prevalence of gastro-oesophageal reflux disease with upper gastrointestinal symptoms without heartburn and regurgitation.
Vakil N; Wernersson B; Ohlsson L; Dent J
United European Gastroenterol J; 2014 Jun; 2(3):173-8. PubMed ID: 25360300
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.
Dent J; Vakil N; Jones R; Bytzer P; Schöning U; Halling K; Junghard O; Lind T
Gut; 2010 Jun; 59(6):714-21. PubMed ID: 20551454
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
Monés J
Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
[TBL] [Abstract][Full Text] [Related]
4. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
[TBL] [Abstract][Full Text] [Related]
5. Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease.
Jones R; Horbach S; Sander P; Rydén-Bergsten T
Pharmacoeconomics; 2003; 21(15):1091-102. PubMed ID: 14596628
[TBL] [Abstract][Full Text] [Related]
6. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.
Rosaida MS; Goh KL
Eur J Gastroenterol Hepatol; 2004 May; 16(5):495-501. PubMed ID: 15097043
[TBL] [Abstract][Full Text] [Related]
7. Gastro-oesophageal reflux disorders among Nepalese residing in Southeast Asia.
Chong VH; Padam BC; Hermanta RG; Anand J
Med J Malaysia; 2013 Jun; 68(3):234-8. PubMed ID: 23749013
[TBL] [Abstract][Full Text] [Related]
8. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME
Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637
[TBL] [Abstract][Full Text] [Related]
9. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
[TBL] [Abstract][Full Text] [Related]
10. Beyond heartburn: a systematic review of the extra-oesophageal spectrum of reflux-induced disease.
Hungin AP; Raghunath AS; Wiklund I
Fam Pract; 2005 Dec; 22(6):591-603. PubMed ID: 16024554
[TBL] [Abstract][Full Text] [Related]
11. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy.
Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
Gut; 2014 May; 63(5):720-6. PubMed ID: 23831734
[TBL] [Abstract][Full Text] [Related]
12. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care.
Ruigómez A; García Rodríguez LA; Wallander MA; Johansson S; Dent J
Curr Med Res Opin; 2006 Sep; 22(9):1661-8. PubMed ID: 16968569
[TBL] [Abstract][Full Text] [Related]
14. Symptoms of gastro-oesophageal reflux disease in elderly people.
Räihä I; Hietanen E; Sourander L
Age Ageing; 1991 Sep; 20(5):365-70. PubMed ID: 1755393
[TBL] [Abstract][Full Text] [Related]
15. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers.
El-Serag HB; Satia JA; Rabeneck L
Gut; 2005 Jan; 54(1):11-7. PubMed ID: 15591498
[TBL] [Abstract][Full Text] [Related]
16. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
[TBL] [Abstract][Full Text] [Related]
17. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease.
Hayat JO; Gabieta-Somnez S; Yazaki E; Kang JY; Woodcock A; Dettmar P; Mabary J; Knowles CH; Sifrim D
Gut; 2015 Mar; 64(3):373-80. PubMed ID: 24812000
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitor.
Jones R; Patrikios T
Int J Clin Pract; 2008 Dec; 62(12):1844-50. PubMed ID: 19166433
[TBL] [Abstract][Full Text] [Related]
19. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
[TBL] [Abstract][Full Text] [Related]
20. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
Kahrilas PJ; Hughes N; Howden CW
Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
